TOKYO & MUNICH--(BUSINESS WIRE)--The European Medicines Agency (EMA) has validated two marketing authorization applications (MAAs) for Daiichi Sankyo (TSE: 4568) and AstraZeneca’s (LSE/STO/Nasdaq: AZN ...
The FDA accepted Besremi's application for essential thrombocythemia, supported by SURPASS-ET and EXCEED-ET trial results, with a review target date of August 30, 2026. Essential thrombocythemia is a ...
HandicapMD provides a clearer, clinician-led pathway for disability parking permit evaluations, helping patients and ...
Mobile devices provide individuals with rapid and frequent access to electronic patient portals. We investigated how oncology patients use this technology to review test results and communicate with ...
This article is part of a series sponsored by HLTH highlighting topics that will be discussed at the HLTH conference November 13-16 in Las Vegas. Register today. Remote patient monitoring is one of ...
LITTLE ROCK, Ark. (KTHV) -- As of Friday, patients and hopeful growers and sellers of medical marijuana can turn in their applications. Patients can turn in applications for a registry I.D. Card, good ...
At Geisinger in Pennsylvania, a pilot program to bring care to the homes of older patients with complex healthcare needs has shown a 35% reduction in visits to the emergency department visits, a 40% ...
Patients with diabetes often have to see many different stakeholders who each specialise in different aspects of their treatment. Researchers from WMG, University of Warwick surveyed patients on their ...
Thirty-three female patients undergoing elective breast cancer surgery used MMS. The median age was 58 years. Nineteen patients underwent lumpectomy, and 14 underwent mastectomy. Users logged on to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback